JGC
RVMD icon

J. Goldman & Co’s Revolution Medicines RVMD Stock Holding History

J. Goldman & Co’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-10,179
Closed -$811K – 944
2025
Q4 		$811K Sell
10,179
-4,187
-29% -$275K 0.03% 414
2025
Q3 		$671K Sell
14,366
-6,377
-31% -$250K 0.03% 360
2025
Q2 		$763K Sell
20,743
-5,069
-20% -$195K 0.02% 353
2025
Q1 		$913K Sell
25,812
-523
-2% -$21.2K 0.03% 372
2024
Q4 		$1.15M Buy
+26,335
New +$1.33M 0.04% 313
2023
Q4 		– Sell
-22,135
Closed -$613K – 513
2023
Q3 		$613K Buy
+22,135
New +$657K 0.03% 265

Other funds holding RVMD

FCM
Farallon Capital Management San Francisco, California $15.3B AUM 50.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return